CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa
2006

CD4 Cell Count Recovery in HIV Patients Starting Treatment in Africa

Sample size: 596 publication Evidence: moderate

Author Information

Author(s): Stephen D Lawn, Landon Myer, Linda-Gail Bekker, Robin Wood

Primary Institution: The Desmond Tutu HIV Centre, University of Cape Town

Hypothesis

Advanced pre-treatment immunodeficiency diminishes the capacity for CD4 cell count recovery during ART.

Conclusion

Patients with very low baseline CD4 counts can recover their immune function during ART, but they may take longer to reach safe CD4 levels.

Supporting Evidence

  • CD4 cell counts increased from 97 cells/μl to 261 cells/μl after 48 weeks of treatment.
  • 51% of patients had CD4 counts <100 cells/μl at baseline, which decreased to 4% at 48 weeks.
  • Patients with baseline CD4 counts <50 cells/μl had similar rates of initial recovery compared to those with higher counts.

Takeaway

People with very low immune cells can still get better when they start treatment for HIV, but it might take them longer to feel safe and healthy.

Methodology

The study measured CD4 cell counts over 48 weeks in ART-naïve individuals starting treatment in a community-based program.

Potential Biases

Survival bias may have affected the findings, as patients with the lowest CD4 counts had a higher risk of death.

Limitations

The study only analyzed CD4 cell recovery during the first year of ART, and long-term outcomes remain undetermined.

Participant Demographics

Median age was 32 years, 75% were female, and most lived in low socioeconomic conditions.

Statistical Information

P-Value

0.007

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2334-6-59

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication